Skip to main content
Fig. 7 | Cancer Cell International

Fig. 7

From: Integrating bioinformatics and experimental validation to unveil disulfidptosis-related lncRNAs as prognostic biomarker and therapeutic target in hepatocellular carcinoma

Fig. 7

TMB analyses and drug sensitivity between high- and low-risk groups. (A-B) Waterfall plot displaying the mutation information of the genes with high mutation frequencies in the high- (A) and low- (B) risk groups. (C) Kaplan–Meier curve for OS of patients with HCC in high and low TMB (p = 0.031). (D) Kaplan–Meier curve for OS of patients with HCC according to the TMB and the risk signature of DRLs. (E) The TIDE scores of high- and low-risk groups. (F-H) The correlation between the risk score of DRLs signature and sensitivity of drugs such as sorafenib (F), 5-Fluorouracil (G), and doxorubicin (H). ***p < 0.001

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us